Plum SEC
Menu
Korean Market
Privacy Policy
Korean Market
Star Rating
Reset (View All)
★★★★★
★★★★
★★★
★★
★
★
★
★★
★★★
★★★★
★★★★★
All Disclosures
Search
EXCH
Pangen Biotech
★
Pangen Biotech Selected as Negotiation Partner for KNIH's SFTS Therapeutic Antibody R&D Project – KRW 2.75 Billion Government Contract
05/27/2026, 02:17 PM
PERI
Pangen Biotech
★
PanGen Q1 2026: Revenue 3.73B KRW, Operating Profit Down but Net Profit Up, Debt Ratio 9%
05/14/2026, 10:55 AM